Skip to main content
Georgetown University researchers are developing a 3D printable bone graft scaffold utilizing pectin, a polysaccharide derived from plant cell walls, as a sustainable and biocompatible material.
Technology
2 min read

Georgetown University researchers are developing a 3D printable bone graft scaffold utilizing pectin, a polysaccharide derived from plant cell walls, as a sustainable and biocompatible material.

Originally reported by 3Druck

Georgetown University researchers are developing a 3D printable bone graft scaffold utilizing pectin, a polysaccharide derived from plant cell walls, as a sustainable and biocompatible material. The research team is focused on optimizing the rheological properties of pectin-based hydrogels to ensure compatibility with extrusion-based 3D printing systems. By leveraging the natural structural integrity of pectin, the project aims to create scaffolds that support osteoconduction while maintaining a controlled degradation rate within the human body. This work is currently in the experimental phase at the university's Washington, D.C. facilities, targeting advancements in regenerative medicine and orthopedic implant design.

The integration of plant-derived polymers into medical additive manufacturing addresses the critical need for sustainable, cost-effective, and highly biocompatible materials in bone tissue engineering. While current standards often rely on synthetic polymers like PCL or PLA, or complex ceramic composites, pectin offers a renewable alternative that may reduce the environmental footprint of medical device production. The global bone graft substitute market is projected to reach approximately $4 billion by 2030, driven by an aging population and the rising prevalence of orthopedic conditions. Georgetown's research positions itself within the materials science segment of the AM value chain, competing with established bio-ink developers that focus on collagen, gelatin, and synthetic hydrogels for clinical applications.

This research represents a foundational step in material characterization rather than an immediate commercial product launch. To move toward clinical viability, the team must demonstrate consistent mechanical performance under physiological loads and secure regulatory approval for the material's degradation byproducts. Future efforts should prioritize standardized testing protocols to compare the structural integrity of pectin scaffolds against existing FDA-cleared synthetic alternatives.

Topics

Georgetown University3D printingpectinbone graftsbiomaterialsregenerative medicineextrusion printingUS
Read Original

How This Connects

6 related events
  1. Same pattern

    Nuopu Regenerative Medicine receives Class III medical device registration for AM-extruded bone filler

  2. Same pattern

    Cyfuse partners with Keio University and Fujita Health University for 3D bioprinted knee joint clinical trials

  3. Same pattern

    Beijing Institute of Technology researchers Dr.

  4. Same pattern

    Aspect Biosystems secures $280M to scale bioprinted tissue therapy production in Canada.

  5. This article

    Georgetown University researchers are developing a 3D printable bone graft scaffold utilizing pectin, a polysaccharide derived from plant cell walls, as a sustainable and biocompatible material.

  6. Same pattern

    EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days.

  7. Same pattern

    Washington State University researchers developed the first fully synthetic, 3D-printed beating heart model for surgical rehearsal.